New avenues for anti-inflammatory therapy

Nature Medicine

Volumn 8, Issue 2, 2002, Pages 117-118

  Mackay, Charles R ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE CCL27; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR10; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; HUMAN; LEUKOCYTE MIGRATION; MEMORY CELL; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; TISSUE SPECIFICITY;

ANTI-INFLAMMATORY AGENTS; CHEMOKINES, CC; HUMANS; INFLAMMATION; RECEPTORS, CHEMOKINE; SKIN; T-LYMPHOCYTES;

EID: 0036173457     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0202-117     Document Type: Short Survey

References (8)

1. CCL27/CCR10 interactions regulate T cell-mediated skin inflammation
2. Lymphocyte homing and homeostasis
3. T cell function and migration. Two sides of the same coin
4. CTACKa skin-associated chemokine that preferentially attracts skin-homing memory T cells
5. + T cells activated in cutaneous or mucosal lymphoid tissues
6. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
7. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cellattracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin
8. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity